University of Pittsburgh Cancer Institute (UPCI)

CCSG Acknowledgement

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the UPCI CCSG support, and they are tracking compliance. If a UPCI CCSG-supported Shared Resource provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the UPCI [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904."

Shared Resource Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the UPCI CCSG support.


Overview

Novel Chemistries and Systems Biology

The UPCI Chemical Biology Facility (ChBF) is a major, cancer-focused component of the University of Pittsburgh Drug Discovery Institute, a state-of-the-art resource that facilitates the discovery and development of novel therapeutics. In addition to providing access to robust, sensitive, rapid, and cost-effective assays capable of screening a wide range of molecular targets against hundreds of thousands of existing and novel compounds, the ChBF provides guidance on designing and executing drug discovery and development projects from target and lead discovery through preclinical development.

Read more about ChBF collaborative research projects that are focused on understanding cancer and identifying novel therapeutic agents and approaches to discovery and development.